Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02235038 · ClinicalTrials.gov registry record · NA

Metabolic Fuels Study

A NA study of Obesity, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
30
Enrollment target
4
Study locations

NCT02235038: Completed NA study of Obesity, sponsored by Boston Children's Hospital.

NCT02235038 is a NA study of Obesity that has completed, run by Boston Children's Hospital. The registered enrollment target is 30 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02235038, a NA study of Obesity, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
4
Study locations

Study Summary

This study will evaluate a potential physiologic mechanism underlying the effects of dietary composition on control of body weight

Primary Outcome

Post-prandial energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, lactate and ketoacids), as measured during a 24 hr inpatient admission. Time of interest includes 2.5 - 5 hr in the postprandial period after breakfast, lunch and dinner.

Conditions Studied

Interventions

  • BEHAVIORAL Low carbohydrate diet
  • BEHAVIORAL Moderate carbohydrate diet
  • BEHAVIORAL High carbohydrate diet

Study Locations (4)

Massachusetts

  • Boston Children's Hospital - Boston
  • Brigham & Women's Hospital - Boston
  • Boston Medical Center - Boston
  • Framingham State University - Framingham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2014-10
Est. Completion 2017-05
Phase NA
Boston Children's Hospital

462 total trials

What the finished NCT02235038 record still lists

NCT02235038 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Low carbohydrate diet is the first listed.

NCT02235038 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02235038 about?

NCT02235038 is a clinical study titled "Metabolic Fuels Study". This study will evaluate a potential physiologic mechanism underlying the effects of dietary composition on control of body weight

What is the current status of trial NCT02235038?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-10. Estimated completion is 2017-05.

What conditions does trial NCT02235038 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02235038?

The interventions under investigation include: Low carbohydrate diet (BEHAVIORAL), Moderate carbohydrate diet (BEHAVIORAL), High carbohydrate diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT02235038?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02235038 being conducted?

This trial has 4 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02235038's enrollment target sits among peer trials

30 851st of 1053 higher than 173 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02235038, the US trial registry maintained by the National Library of Medicine. NCT02235038 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.